SEC Form 4 · accession 0001127602-15-011048

BIOGEN INC. · BIIB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 10, 2015

Accepted (ET)

Mar 11, 2015 · 4:13 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000875045

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 10, 2015	M	3,125	$46.99	A	17,998	D
Common Stock^F2,F3	Mar 10, 2015	S	200	$410.605	D	17,798	D
Common Stock^F2,F4	Mar 10, 2015	S	300	$411.463	D	17,498	D
Common Stock^F2,F5	Mar 10, 2015	S	700	$412.969	D	16,798	D
Common Stock^F2,F6	Mar 10, 2015	S	1,000	$413.985	D	15,798	D
Common Stock^F2,F7	Mar 10, 2015	S	300	$415.143	D	15,498	D
Common Stock^F2,F8	Mar 10, 2015	S	525	$416.247	D	14,973	D
Common Stock	Mar 10, 2015	S	100	$417.27	D	14,873	D
Common Stock	Mar 10, 2015	M	500	$52.22	A	15,373	D
Common Stock^F2,F9	Mar 10, 2015	S	400	$410.055	D	14,973	D
Common Stock	Mar 10, 2015	S	100	$411.33	D	14,873	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F10,F11	$46.99	Mar 10, 2015	M	3,125	D	—	May 24, 2016	Common Stock	3,125	0	D
Stock Option (Right to Buy)^F12	$52.22	Mar 10, 2015	M	500	D	—	May 30, 2017	Common Stock	500	5,450	D

F1Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F10Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
F11Options will vest in their entirety on 05/25/2007 provided that the Reporting Owner is then a member of the Issuer's Board of Directors.
F12Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.
F2Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F3This represents the weighted average price for shares sold at a range between $410.18 (low) and $411.03 (high)
F4This represents the weighted average price for shares sold at a range between $411.35 (low) and $411.53 (high).
F5This represents the weighted average price for shares sold at a range between $412.47 (low) and $413.18 (high).
F6This represents the weighted average price for shares sold at a range between $413.62 (low) and $414.28 (high).
F7This represents the weighted average price for shares sold at a range between $414.82 (low) and $415.71 (high).
F8This represents the weighted average price for shares sold at a range between $415.90 (low) and $416.54 (high).
F9This represents the weighted average price for shares sold at a range between $409.67 (low) and $410.35 (high).